Roundup maker Bayer AG has been ordered by a jury to pay $80 million in damages to a plaintiff who developed non-Hodgkin’s lymphoma after years of using the weed-killing product. Last week’s verdict comes several months after another jury awarded $289 million against Bayer in a different Roundup case. Roundup was originally developed and marketed by Monsanto, which was acquired recently by pharmaceutical and chemical giant Bayer AG.
These two cases are the first two Roundup claims to have gone to trial. It is estimated that there are at least 11,000 plaintiffs suing Bayer for producing and marketing the popular product.
The main active ingredient in Roundup is glyphosate. Although glyphosate is common in the United States, other countries have curtailed its use. In spite of Bayer’s claims that the product is safe, there is growing evidence that glyphosate causes an increased risk of non-Hodgkin’s lymphoma, which is a type of cancer that originates and can spread from the lymphatic system.
Grewal Law, PLLC, is currently investigating Roundup claims. If you or a loved one has developed non-Hodgkin’s lymphoma after using Roundup, contact us today for a free, confidential consultation.
